Schirmeister T - Search Results

1

(S)-Thiirancarboxylic acid as a reactive building block for a new class of cysteine protease inhibitors.

Schirmeister T. Schirmeister T. Bioorg Med Chem Lett. 2000 Dec 4;10(23):2647-51. doi: 10.1016/s0960-894x(00)00549-7. Bioorg Med Chem Lett. 2000. PMID: 11128643

2

New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.

Schirmeister T. Schirmeister T. J Med Chem. 1999 Feb 25;42(4):560-72. doi: 10.1021/jm981061z. J Med Chem. 1999. PMID: 10052963

3

Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition.

Schirmeister T, Peric M. Schirmeister T, et al. Bioorg Med Chem. 2000 Jun;8(6):1281-91. doi: 10.1016/s0968-0896(00)00058-4. Bioorg Med Chem. 2000. PMID: 10896108

4

Non-peptidic inhibitors of cysteine proteases.

Schirmeister T, Kaeppler U. Schirmeister T, et al. Mini Rev Med Chem. 2003 Jun;3(4):361-73. doi: 10.2174/1389557033488079. Mini Rev Med Chem. 2003. PMID: 12678829 Review.

5

Cysteine protease inhibitors containing small rings.

Schirmeister T, Klockow A. Schirmeister T, et al. Mini Rev Med Chem. 2003 Sep;3(6):585-96. doi: 10.2174/1389557033487935. Mini Rev Med Chem. 2003. PMID: 12871161 Review.

6

Thiirancarboxamides as inhibitors of papain.

Bruno G, Schirmeister T. Bruno G, et al. Among authors: schirmeister t. Arch Pharm (Weinheim). 2004 Feb;337(2):90-5. doi: 10.1002/ardp.200300820. Arch Pharm (Weinheim). 2004. PMID: 14981665

7

Theoretical studies about the influence of different ring substituents on the nucleophilic ring opening of three-membered heterocycles and possible implications for the mechanisms of cysteine protease inhibitors.

Helten H, Schirmeister T, Engels B. Helten H, et al. Among authors: schirmeister t. J Org Chem. 2005 Jan 7;70(1):233-7. doi: 10.1021/jo048373w. J Org Chem. 2005. PMID: 15624927

8

Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor.

Martina E, Stiefl N, Degel B, Schulz F, Breuning A, Schiller M, Vicik R, Baumann K, Ziebuhr J, Schirmeister T. Martina E, et al. Among authors: schirmeister t. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5365-9. doi: 10.1016/j.bmcl.2005.09.012. Epub 2005 Oct 10. Bioorg Med Chem Lett. 2005. PMID: 16216498 Free PMC article.

9

A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.

Kaeppler U, Stiefl N, Schiller M, Vicik R, Breuning A, Schmitz W, Rupprecht D, Schmuck C, Baumann K, Ziebuhr J, Schirmeister T. Kaeppler U, et al. Among authors: schirmeister t. J Med Chem. 2005 Nov 3;48(22):6832-42. doi: 10.1021/jm0501782. J Med Chem. 2005. PMID: 16250642

10

Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.

Vicik R, Hoerr V, Glaser M, Schultheis M, Hansell E, McKerrow JH, Holzgrabe U, Caffrey CR, Ponte-Sucre A, Moll H, Stich A, Schirmeister T. Vicik R, et al. Among authors: schirmeister t. Bioorg Med Chem Lett. 2006 May 15;16(10):2753-7. doi: 10.1016/j.bmcl.2006.02.026. Epub 2006 Mar 3. Bioorg Med Chem Lett. 2006. PMID: 16516467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters